High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric Adenocarcinoma

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lee, Jeeyun ^a   van Hummelen, Paul ^b   Go, Christina ^b   Palescandolo, Emanuele ^b   Jang, Jiryeon ^a   Park, Ha Young ^a   Kang, So Young ^a   Park, Joon Oh ^a   Kang, Won Ki ^a   MacConaill, Laura ^b   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FORMALDEHYDE; PARAFFIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; PROTEIN P53;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; APC GENE; ARTICLE; CANCER PALLIATIVE THERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; CTNNB1 GENE; EMBEDDING; EPSTEIN BARR VIRUS; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; P53 GENE; PIK3CA GENE; SOMATIC MUTATION; STK11 GENE; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION RATE; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; STOMACH NEOPLASMS;

EID: 84862502170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038892     Document Type: Article

References (22)

1. Accessed on May 23 2012. Available:http://www.seer.cancer.gov/statfacts/html/stomach.html. (2012)
2. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, et al. (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376: 687 697.
3. Lee J, Lim do H, Kim S, Park SH, Park JO, et al. (2012) Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial. J Clin Oncol 30: 268 273.
4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725 730.
5. MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, et al. (2009) Profiling critical cancer gene mutations in clinical tumor samples. PLoS One 4: e7887.
6. Macconaill LE, Van Hummelen P, Meyerson M, Hahn WC, (2011) Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges. Cancer Discov 1: 297.
7. Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, et al. (2010) Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma. Cancer Research 70: 4719 4727.
8. Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, et al. (2010) Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus-Associated Gastric Carcinoma. Gastroenterology 139: 84 U123.
9. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, et al. (2011) Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 43: 1219 1223.
10. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, et al. (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet.
11. Li VS, Wong CW, Chan TL, Chan AS, Zhao W, et al. (2005) Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5: 29.
12. Samuels Y, Waldman T, (2011) Oncogenic Mutations of PIK3CA in Human Cancers. Phosphoinositide 3-Kinase in Health and Disease, Vol 2 347: 21 41.
13. Samuels Y, Wang ZH, Bardelli A, Silliman N, Ptak J, et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554 554.
14. Levine AJ, (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323 331.
15. Oki E, Zhao Y, Yoshida R, Egashira A, Ohgaki K, et al. (2009) The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract. Digestion 79: 33 39.
16. Hsieh LL, Lin PJ, Chen TC, Ou JT, (1998) Frequency of Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Cancer Lett 129: 125 129.
17. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, et al. (1992) Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52: 6696 6698.
18. Accessed on May 23 availanle:http://www.sanger.ac.uk/perl/genetics/CGP/cosmic?action=byhist&sn=stomach&ss. (2012)
19. Wang YP, Friedl W, Lamberti C, Nothen MM, Kruse R, et al. (1998) A novel missense mutation in the DNA mismatch repair gene hMLH1 present among East Asians but not among Europeans. Human Heredity 48: 87 91.
20. Kim JC, Roh SA, Koo KH, Ka IH, Kim HC, et al. (2004) Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam Cancer 3: 129 137.
21. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, et al. (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39: 347 351.
22. Matulonis UA, Hirsch M, Palescandolo E, Kim E, Liu J, et al. (2011) High throughput interrogation of somatic mutations in high grade serous cancer of the ovary. PLoS One 6: e24433.